← Back to Clinical Trials
Recruiting NCT04648124

NCT04648124 VIsual Cerebral ConnecTivity On Functional Magnetic Resonance Imaging in Patients With Hereditary REtinal Dystrophies

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04648124
Status Recruiting
Phase
Sponsor Fondation Ophtalmologique Adolphe de Rothschild
Condition Vision Functional Brain Networks in Patients With Hereditary Retinal Dystrophies
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2021-01-04
Primary Completion 2026-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
IRMf-r (séquence resting state)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 200 participants in total. It began in 2021-01-04 with a primary completion date of 2026-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The Rothschild Foundation A Hospital follows a cohort of approximately 300 patients with hereditary retinal dystrophy. These patients are followed in ophthalmology consultation every year. In order to plan the MRI on the day of the annual consultation and to avoid additional travel for patients, patients will be informed of the study before the consultation (transmission of an information letter and the information note from study). If patients agree to participate in the study, rMRI will be scheduled. During the follow-up ophthalmologic consultation, after checking the inclusion and non-inclusion criteria, the study information will be repeated, and patients who still agree to participate will sign the study consent.

Eligibility Criteria

Inclusion Criteria: * Patient over 18 years old * Diagnostic clinique de dystrophie rétinienne héréditaire ou maculopathie héréditaire, syndromique ou non syndromique * Artificial vision treatment such as a retinal implant, or optogenetics scheduled in the next 6 months * Express consent to participate in the study * Affiliate or beneficiary of a social security scheme Exclusion Criteria: * Patient benefiting from a legal protection measure * Pregnant or breastfeeding woman * Contraindication to MRI (claustrophobia, implanted equipment such as pacemaker). * Other additional ocular pathology that can significantly affect vision * Recent eye surgery less than 3 months old

Contact & Investigator

Central Contact

Amélie YAVCHITZ

✉ ayavchitz@for.paris

📞 0148036454

Principal Investigator

Augustin LECLER

PRINCIPAL INVESTIGATOR

Fondation Ophtalmologique A. de Rothschild

Frequently Asked Questions

Who can join the NCT04648124 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Vision Functional Brain Networks in Patients With Hereditary Retinal Dystrophies. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04648124 currently recruiting?

Yes, NCT04648124 is actively recruiting participants. Contact the research team at ayavchitz@for.paris for enrollment information.

Where is the NCT04648124 trial being conducted?

This trial is being conducted at Paris, France.

Who is sponsoring the NCT04648124 clinical trial?

NCT04648124 is sponsored by Fondation Ophtalmologique Adolphe de Rothschild. The principal investigator is Augustin LECLER at Fondation Ophtalmologique A. de Rothschild. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology